Effective with date of service Jan. 27, 2023, Medicaid and NC Health Choice cover lenacapavir injection
Topics Related to Division of Health Benefits
Federal support ending for Resource Utilization Groups III and IV on federally required assessments for patients effective Oct. 1, 2023.
Pegfilgrastim-FpgkInjection, for Subcutaneous Use (Stimufend®) HCPCS Code J3590 - Billing Guidelines
Effective with date of service Jan. 23, 2023, the Medicaid and NC Health Choice programs cover pegfilgrastim-fpgk
Effective with date of service Jan. 20, 2023, the Medicaid and NC Health Choice programs cover fecal microbiota, live - jslm suspension, for rectal use (Rebyota).
Effective with date of service Jan. 27, 2023, the Medicaid and NC Health Choice programs covers ublituximab-xiiy injection, for intravenous use (Briumvi)
Effective with date of service Jan. 30, 2023, the Medicaid and NC Health Choice programs cover bendamustine hydrochloride injection, for intravenous use (Baxter).
Effective immediately, all providers must use the Electronic Visit Verification vendor of their choice for every home health visit.
Effective April 1, 2023, NC Medicaid covers ambulatory blood pressure monitoring. This helps confirm or exclude suspected hypertension.
In compliance with federal requirements, beneficiary consent is required for all voluntary sterilizations.
Clarifies requirements related to Research Based-Behavioral Health Treatment and Specialized Consultative Services and New Taxonomy